Mallinckrodt Tries To Stop Another Oxide Rival

By Andrew Karpan · January 3, 2023, 5:40 PM EST

Pharmaceutical company Mallinckrodt is going to court to try to stop a French industrial gas company from marketing nitric oxide that would compete with the Inomax brand of oxide that Mallinckrodt...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Mallinckrodt Pharmaceuticals Ireland Limited et al v. Airgas Therapeutics LLC et al

Case Number

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

December 30, 2022

Recent Articles By Andrew

July 11, 2024
GSK Asks Judge To Rule In Teva IP Case, Citing Opioid Deals
July 09, 2024
South Africa Drops J&J Probe After TB Drug Price Cuts
June 26, 2024
Ga. High Court Told To Skip Inventor's 'Clerical Mistake' Fight
June 13, 2024
IP Forecast: Cooley Atty Faces DQ Bid Over Past Patent Work
June 10, 2024
5 Teva Inhaler Patents Kicked Out Of Orange Book
May 31, 2024
Samsung Strikes First With Smart Ring IP Suit Against Oura
May 22, 2024
Inventor To Take $102M IP Malpractice Row To Ga. High Court
May 21, 2024
Sens. Challenge Pharma Lobbyist Over Patent Abuse
May 14, 2024
The PREP Immunity Question Won't Be Decided Yet
May 13, 2024
USPTO Eyes Change To Patent Applicants' Disclaimer Practice